| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
boule homolog, RNA binding protein | 0.792 | 0.346 | 5.8E-02 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
group | 0.500 | None | 0.978 | 4 | 10 | 2002 | 2019 | ||||||||
|
BUB1 mitotic checkpoint serine/threonine kinase | 0.528 | 0.731 | 4.9E-09 |
|
group | 0.310 | None | 1.000 | 0 | 0 | 2002 | 2002 | ||||||||
|
BUB1 mitotic checkpoint serine/threonine kinase B | 0.502 | 0.808 | 7.0E-10 |
|
group | 0.330 | None | 1.000 | 0 | 0 | 2002 | 2009 | ||||||||
|
Cdk5 and Abl enzyme substrate 1 | 0.700 | 0.385 | 5.5E-03 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
calcium binding tyrosine phosphorylation regulated | 0.792 | 0.192 | 2.3E-06 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
CDK2 associated cullin domain 1 | 0.638 | 0.577 | 0.96 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
calcium binding and coiled-coil domain 2 | 0.722 | 0.423 | 1.0E-04 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
calreticulin | 0.413 | 0.923 | 0.89 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
caspase 8 | 0.404 | 0.923 | 3.7E-06 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2003 | 2007 | ||||||||
|
chromobox 5 | 0.621 | 0.731 | 0.93 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
cyclin D2 | 0.477 | 0.808 | 0.99 |
|
group | 0.420 | None | 1.000 | 1 | 3 | 2011 | 2019 | ||||||||
|
CD109 molecule | 0.595 | 0.654 | 2.3E-44 |
|
group | 0.300 | None | 1.000 | 2 | 0 | 2008 | 2011 | ||||||||
|
CD226 molecule | 0.548 | 0.769 | 3.9E-02 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
CD9 molecule | 0.528 | 0.769 | 4.7E-03 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
group | 0.500 | None | 0.950 | 2 | 2 | 1999 | 2019 | ||||||||
|
cadherin 22 | 0.821 | 0.192 | 0.50 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
cadherin 5 | 0.561 | 0.692 | 0.51 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
cadherin 7 | 0.769 | 0.231 | 0.60 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
CEBPA divergent transcript | 0.821 | 0.115 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
chromodomain helicase DNA binding protein 1 | 0.628 | 0.692 | 1.00 |
|
group | 0.400 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
chromodomain helicase DNA binding protein 5 | 0.604 | 0.500 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
group | 0.380 | None | 1.000 | 1 | 0 | 2003 | 2019 | ||||||||
|
cyclin Pas1/PHO80 domain containing 1 | 0.931 | 0.115 | 7.6E-09 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 |